The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Open accessPublished version of a preprint
Abstract
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. Here, we systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in unexposed individuals, exposed family members, and individuals with acute or convalescent COVID-19. Acute-phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent-phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative exposed family members and convalescent individuals with a history of asymptomatic and mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits broadly directed and functionally replete memory T cell responses, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This cross-reactivity largely originates from previous exposure to circulating common cold coronaviruses [110-116].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [113]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“lymphocytes from 20% to 50% of unexposed donors display significant reactivity to SARS-CoV-2 Ag peptide pools (Figure 6).”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [113]
The cited source says what the claim attributes to it.
In the citing paper
“A vast majority of responding CD4+ and CD8+ T cells displayed an activated/cycling (CD38+ HLA-DR+ Ki67+ PD-1+) phenotype [113]”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [113]
The cited source says what the claim attributes to it.
In the citing paper
“and SARS-CoV-2-specific memory T cells were detected in convalescent patients, even in exposed individuals who are seronegative.30, 31”
From Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial (2022) · cites this paper as [31]
In the citing paper
“Virus-specific CD8+ and CD4+ T cells, including CD8+ memory T cells, are present in patients who have recovered from COVID-19 (refs44,45), but their importance in protection against future infection and/or severe disease remain uncertain44,46–48.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [45]
In the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [45]
In the citing paper
“Studies of acute and convalescent COVID-19 patients have observed that SARS-CoV-2-specific T cell responses are significantly associated with milder disease (Liao et al., 2020; Rydyznski Moderbacher et al., 2020; Sekine et al., 2020; Zhou et al., 2020b), suggesting that T cell responses may be important for control and resolution of a primary SARS-CoV-2 infection.”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Sekine et al., 2020
In the citing paper
“Overall, circulating SARS-CoV-2-specific CD8+ T cells are less consistently observed than CD4+ T cells (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Sekine et al., 2020
In the citing paper
“Last, there were initially great concerns about potential immune deviation to Th2 and immunopathogenesis (Peeples, 2020), but SARS-CoV-2-specific CD4+ T cells from patients consistently do not have Th2 characteristics (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Sekine et al., 2020
In the citing paper
“CD4+ T cell responses to SARS-CoV-2 are more prominent than CD8+ T cell responses (Grifoni et al., 2020; Sekine et al., 2020) and have been associated with control of primary SARS-CoV-2 infection (Rydyznski Moderbacher et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Sekine et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationThe third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686
Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa379 · Cited by 2,361
Self-citationSARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,812
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768
Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,726
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martínez-Colón, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0944-y · Cited by 1,493
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Braun, J., Loyal, L., Frentsch, M., Wendisch, D., Georg, P., Kurth, F., Hippenstiel, S., Dingeldey, M., Kruse, B., Fauchere, F., et al. (2020) · Nature · doi:10.1038/s41586-020-2598-9 · Cited by 1,310
A human monoclonal antibody blocking SARS-CoV-2 infection
Wang, C., Li, W., Drabek, D., Okba, N. M. A., van Haperen, R., Osterhaus, A. D. M. E., van Kuppeveld, F. J. M., Haagmans, B. L., Grosveld, F. G., & Bosch, B. (2020) · Nature Communications · doi:10.1038/s41467-020-16256-y · Cited by 1,128
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ni, L., Ye, F., Cheng, M., Yu, F., Deng, Y., Zhao, H. J., Peng, W., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,085
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2025179 · Cited by 1,021
Thevarajan, I., Nguyen, T. H. O., Koutsakos, M., Druce, J. D., Caly, L., van de Sandt, C. E., Jia, X., Nicholson, S. R., Catton, M. C., Cowie, B., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0819-2 · Cited by 993
Wilkinson, T. M., Li, C. K. F., Chui, C. S. C., Huang, A. K. Y., Perkins, M., Liebner, J. C., Lambkin-Williams, R., Gilbert, A., Oxford, J., Nicholas, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2612 · Cited by 974
Zheng, H.-Y., Zhang, M., Yang, C.-X., Zhang, N., Wang, X.-C., Yang, X.-P., Dong, X.-Q., & Zheng, Y.-T. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0401-3 · Cited by 940
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E. F., Toh, M. P. H., & Lee, V. J. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6914e1 · Cited by 915
Cellular immune correlates of protection against symptomatic pandemic influenza
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013) · Nature Medicine · doi:10.1038/nm.3350 · Cited by 862
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816 · cited 3×
“(Chandrashekar et al., 2020), and similarly, there is limited evidence of reinfection in humans with previously documented COVID-19 (Kirkcaldy et al.”
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
Woloshin, S., Patel, N. G., & Kesselheim, A. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2015897 · Cited by 805
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
Miller, J. D., van der Most, R. G., Akondy, R. S., Glidewell, J. T., Albott, S., Masopust, D., Murali-Krishna, K., Mahar, P. L., Edupuganti, S., Lalor, S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.020 · Cited by 601
The time course of the immune response to experimental coronavirus infection of man
Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496
Precopio, M., Betts, M. R., Parrino, J., Price, D. A., Emma Gostick, D., Ambrozak, D. R., Asher, T. E., Douek, D. C., Harari, A., Pantaleo, G., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062363 · Cited by 492
Self-citationT Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 488
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437
Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411 · cited 2×
“This phenotype has been associated with stem-like properties (Betts et al., 2006; Blom et al., 2013; Demkowicz et al., 1996; Fuertes Marraco et al., 2015; Precopio et al., 2007).”
BackgroundPrice, D. A., Brenchley, J. M., Ruff, L. E., Betts, M. R., Hill, B. J., Roederer, M., Koup, R. A., Migueles, S. A., Emma Gostick, D., Wooldridge, L., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051357 · Cited by 366
Self-citationSeydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.001 · Cited by 364
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
Zhao, J., Alshukairi, A. N., Baharoon, S. A., Ahmed, W., Bokhari, A. A., Nehdi, A., Layqah, L. A., Alghamdi, M., Algethamy, M., Dada, A. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5393 · Cited by 262
The clinical course and its correlated immune status in COVID-19 pneumonia
He, R., Lu, Z., Zhang, L., Fan, T. T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 235
COVID-19 and Postinfection Immunity
Kirkcaldy, R. D., King, B. A., & Brooks, J. T. (2020) · JAMA · doi:10.1001/jama.2020.7869 · Cited by 230
Human cytotoxic T-cell memory: long-lived responses to vaccinia virus
Demkowicz, W. E., Littaua, R. A., Wang, J., & Ennis, F. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.4.2627-2631.1996 · Cited by 220
Fuertes Marraco, S. A., Soneson, C., Cagnon, L., Gannon, P. O., Allard, M., Maillard, S. A., Montandon, N., Rufer, N., Waldvogel, S., Delorenzi, M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3700 · Cited by 206
Yang, R., Gui, X., & Xiong, Y. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10182 · Cited by 199
Buggert, M., Nguyen, S., de Oca, G. S. M., Bengsch, B., Darko, S. W., Ransier, A., Roberts, E. R., Alcazar, D. D., Brody, I. B., Vella, L. A., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar4526 · Cited by 165
Self-citationShin, H., Kim, Y., Kim, G., Lee, J. Y., Jeong, I., Joh, J.-S., Kim, H., Chang, E., Sim, S. Y., Park, J.-S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy595 · Cited by 149
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors
Alshukairi, A. N., Khalid, I., Ahmed, W., Dada, A. M., Bayumi, D. T., Malic, L. S., Althawadi, S., Ignacio, K. H., Alsalmi, H., Al-Abdely, H. M., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2206.160010 · Cited by 141
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent IndividualsPreprint
Robbiani, D. F., Gaebler, C., Muecksch, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.13.092619 · Cited by 138
Yang, L., Peng, H., Zhu, Z.-L., Li, G., Huang, Z., Zhao, Z., Koup, R. A., Bailer, R. T., & Wu, C. Y. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.05.002 · Cited by 115
Blom, K. G., Braun, M., Ivarsson, M. A., Gonzalez, V. D., Falconer, K., Moll, M., Ljunggren, H., Michaëlsson, J., & Sandberg, J. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202234 · Cited by 108
Self-citationLoss of T cell responses following long-term cryopreservation
Owen, R. E., Sinclair, E., Emu, B., Heitman, J. W., Hirschkorn, D. F., Epling, C. L., Tan, Q. X., Custer, B., Harris, J. M., Jacobson, M. Z., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.07.012 · Cited by 103
Has Sweden’s controversial covid-19 strategy been successful?
Habib, H. (2020) · BMJ · doi:10.1136/bmj.m2376 · Cited by 102
Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
Plebani, M., Padoan, A., Negrini, D., Carpinteri, B., & Sciacovelli, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.050 · Cited by 101
COVID-19 vaccines: neutralizing antibodies and the alum advantage
Hotez, P. J., Corry, D. B., Strych, U., & Bottazzi, M. E. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0358-6 · Cited by 79
Will antibody tests for the coronavirus really change everything?
Mallapaty, S. (2020) · Nature · doi:10.1038/d41586-020-01115-z · Cited by 73
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualPreprint
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.12.091298 · Cited by 64
Buggert, M., Norström, M. M., Salemi, M., Hecht, F. M., & Karlsson, A. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302253 · Cited by 11
Self-citation
Flagged first, then by citations
1 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179
Metadata
- Authors
- Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., Wullimann, D. J., Kammann, T., Emgård, J., Parrot, T., Folkesson, E., Akber, M., Berglin, L., Bergsten, H., Brighenti, S., Brownlie, D., Butrym, M., Chambers, B., Chen, P., Jeannin, M. C., Grip, J., Gomez, A. C., Dillner, L., Lozano, I. D., Dzidic, M., Tullberg, M. F., Färnert, A., Glans, H., Haroun-Izquierdo, A., Henriksson, E., Hertwig, L., Kalsum, S., Kokkinou, E., Kvedaraite, E., Loreti, M., Lourda, M., Maleki, K., Malmberg, K.-J., Marquardt, N., Maucourant, C., Michaelsson, J., Mjösberg, J., Moll, K., Muva, J., Mårtensson, J., Nauclér, P., Norrby-Teglund, A., Medina, L. P., Persson, B., Radler, L., Ringqvist, E., Sandberg, J. T., Sohlberg, E., Soini, T., Svensson, M., Tynell, J., Varnaite, R., Kries, A. V., Unge, C., Rooyackers, O., Eriksson, L. I., Henter, J.-I., Sönnerborg, A., Allander, T., Albert, J., Nielsen, M., Klingström, J., Gredmark-Russ, S., Björkström, N. K., Sandberg, J. K., Price, D. A., Ljunggren, H.-G., Aleman, S., & Buggert, M.
- Affiliations
- Karolinska Institutet (SE)
- Karolinska University Hospital (SE)
- National University of General San Martín (AR)
- University Hospital of Wales (GB)
- Corresponding author
- Buggert, Marcus
- ORCID
- Sekine, Takuya
- Strålin, Kristoffer
- Gorin, Jean-Baptiste
- Kamal, Habiba
- Wullimann, David J.
- Kammann, Tobias
- Parrot, Tiphaine
- Folkesson, Elin
- Bergsten, Helena
- Brighenti, Susanna
- Brownlie, Demi
- Butrym, Marta
- Chambers, Benedict
- Chen, Puran
- Grip, Jonathan
- Dillner, Lena
- Dzidic, Majda
- Färnert, Anna
- Glans, Hedvig
- Haroun-Izquierdo, Alvaro
- Hertwig, Laura
- Kalsum, Sadaf
- Kokkinou, Efthymia
- Kvedaraite, Egle
- Maleki, Kimia
- Malmberg, Karl-Johan
- Marquardt, Nicole
- Maucourant, Christopher
- Mjösberg, Jenny
- Mårtensson, Johan
- Nauclér, Pontus
- Ringqvist, Emma
- Sandberg, John Tyler
- Sohlberg, Ebba
- Soini, Tea
- Svensson, Mattias
- Tynell, Janne
- Rooyackers, Olav
- Henter, Jan-Inge
- Sönnerborg, Anders
- Albert, Jan
- Nielsen, Morten
- Klingström, Jonas
- Björkström, Niklas K.
- Sandberg, Johan K.
- Price, David A.
- Ljunggren, Hans-Gustaf
- Aleman, Soo
- Buggert, Marcus
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 183
- Issue
- 1
- Pages
- 158-168.e14
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC7427556
- OpenAlex
- W3048775784
- Cited by
- 1,788
- References
- 58
- Citations by year
- 2026: 50 · 2025: 97 · 2024: 150 · 2023: 221 · 2022: 424 · 2021: 624 · 2020: 220
- FWCI
- 48.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- RIUCAM (submittedVersion, cc-by-nc-nd)
- Funders
- Barncancerfonden
- Svenska Sällskapet för Medicinsk Forskning
- Jeanssons Stiftelser
- National Institutes of Health
- Vetenskapsrådet
- Karolinska Institutet
- Cancerfonden
- Åke Wiberg Stiftelse
- Magnus Bergvalls Stiftelse
- Stiftelsen Clas Groschinskys Minnesfond
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell immunity, memory T cells, convalescent patients, asymptomatic infection, mild COVID-19, cytotoxic T lymphocytes, T cell polyfunctionality, family exposure, disease severity
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Antibodies, Viral, Convalescence, Female, Humans, Immunologic Memory, Male, Middle Aged, Pneumonia, Viral, T-Lymphocytes, Coronavirus Infections, Asymptomatic Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
